Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heritability of Recurrent Aphthous Ulcers: Evidence from a UK Twin Cohort.

Journal of dental research·2026
Same author

A comparative evaluation of ion release characteristics of three different dental varnishes containing fluoride either with CPP-ACP or bioactive glass.

Dental materials : official publication of the Academy of Dental Materials·2019
Same author

Comparison of efficacy of dental varnish containing fluoride either with CPP-ACP or bioglass on root caries: Ex vivo study.

Journal of dentistry·2018
Same author

Effect of Free Sugars on Diabetes, Obesity, and Dental Caries.

Journal of dental research·2016
Same author

The mouth and AIDS: lessons learned and emerging challenges in global oral health: introduction.

Oral diseases·2016
Same author

HIV/AIDS in women and children in India.

Oral diseases·2016

Related Experiment Video

Updated: Jun 3, 2026

Inducing Ischemia-reperfusion Injury in the Mouse Ear Skin for Intravital Multiphoton Imaging of Immune Responses
06:29

Inducing Ischemia-reperfusion Injury in the Mouse Ear Skin for Intravital Multiphoton Imaging of Immune Responses

Published on: December 22, 2016

Immune reconstitution inflammatory syndrome.

A R Tappuni1

  • 1Institute of Dentistry, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, UK. a.r.tappuni@qmul.ac.uk

Advances in Dental Research
|March 29, 2011
PubMed
Summary
This summary is machine-generated.

Immune Reconstitution Inflammatory Syndrome (IRIS) is an inflammatory reaction during immunodeficiency recovery. In HIV patients on antiretroviral therapy, IRIS presents challenges due to immune system restoration.

More Related Videos

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice

Published on: January 31, 2020

Related Experiment Videos

Last Updated: Jun 3, 2026

Inducing Ischemia-reperfusion Injury in the Mouse Ear Skin for Intravital Multiphoton Imaging of Immune Responses
06:29

Inducing Ischemia-reperfusion Injury in the Mouse Ear Skin for Intravital Multiphoton Imaging of Immune Responses

Published on: December 22, 2016

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice

Published on: January 31, 2020

Area of Science:

  • Immunology
  • Infectious Diseases
  • HIV/AIDS Research

Background:

  • Immune Reconstitution Inflammatory Syndrome (IRIS) is a clinical phenomenon in patients recovering from immunodeficiency.
  • IRIS is characterized by an inflammatory response to infections or underlying conditions as the immune system recovers.
  • In Human Immunodeficiency Virus (HIV)-infected individuals, IRIS often arises as a consequence of effective antiretroviral therapy (ART).

Purpose of the Study:

  • To elucidate the complex phenomenon of IRIS in the context of immune recovery, particularly in HIV-infected patients undergoing ART.
  • To understand the immunological mechanisms and clinical manifestations of IRIS.
  • To highlight the diagnostic and therapeutic challenges posed by IRIS.

Main Methods:

  • This abstract is based on a review of existing literature and clinical observations regarding IRIS.
  • The study synthesizes information on the proposed causes, immunological pathways, and clinical presentations of IRIS.
  • Focus is placed on the immunological shifts, including T-cell dynamics and cytokine activity, in HIV patients experiencing IRIS.

Main Results:

  • IRIS involves an inflammatory flare during rapid immune reconstitution, often unmasking or worsening infections.
  • In HIV patients, IRIS is associated with improved immune function (increased CD4+ and CD8+ cells, decreased regulatory T-cells) and exaggerated cytokine release.
  • Clinical presentations are atypical and antigen-dependent; while often self-limiting, severe cases can be life-threatening.

Conclusions:

  • IRIS is a significant complication of successful immune restoration in immunodeficient patients, especially those with HIV on ART.
  • Understanding the immunological underpinnings of IRIS is crucial for clinical management.
  • Early recognition and appropriate intervention, while generally avoiding ART discontinuation, are key to managing IRIS effectively.